Sorafinib in combination with intensive chemotherapy for previously untreated adult FLT3-ITD positive AML: A phase 2 randomised double-blind placebo controlled multi-centre study (ALLG AMLM16)

Name: Sorafinib in combination with intensive chemotherapy for previously untreated adult FLT3-ITD positive AML: A phase 2 randomised double-blind placebo controlled multi-centre study (ALLG AMLM16)
Creator: Health Data Australia Contributor Records
Published: 2024-12-14T18:05:47+08:00

Research Data Australia2024-12-14 收录

急性髓系白血病

药物疗效

数据链接：

https://researchdata.edu.au/sorafinib-combination-intensive-allg-amlm16/2538240 数据链接链接失效反馈

官方服务：

资源简介：

Dataset includes: Data for 102 previously untreated FLT3-ITD positive AML patients Sorafenib in combination with intensive chemotherapy versus placebo group Event-Free survival Safety and measures of efficacy Toxicity QoL data Response rates

提供机构：

Health Data Australia Contributor Records

Sorafinib in combination with intensive chemotherapy for previously untreated adult FLT3-ITD positive AML: A phase 2 randomised double-blind placebo controlled multi-centre study (ALLG AMLM16)

资源简介：

相关数据集